American International Group, Inc. Nektar Therapeutics Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.64 - $3.15 $252 - $1,244	395 Added 0.4%	99,479 $69,000
Q4 2022 Feb 10, 2023	SELL	$2.03 - $4.28 $1,524 - $3,214	-751 Reduced 0.75%	99,084 $223,000
Q3 2022 Nov 14, 2022	BUY	$3.04 - $5.14 $3,532 - $5,972	1,162 Added 1.18%	99,835 $319,000
Q2 2022 Aug 12, 2022	BUY	$3.17 - $6.17 $262,146 - $510,234	82,696 Added 517.59%	98,673 $375,000
Q1 2022 May 13, 2022	SELL	$4.16 - $13.72 $374 - $1,234	-90 Reduced 0.56%	15,977 $86,000
Q4 2021 Feb 11, 2022	SELL	$10.83 - $18.41 $3.25 Million - $5.53 Million	-300,409 Reduced 94.92%	16,067 $217,000
Q3 2021 Nov 12, 2021	SELL	$13.07 - $18.84 $95,763 - $138,040	-7,327 Reduced 2.26%	316,476 $5.68 Million
Q2 2021 Aug 13, 2021	SELL	$16.52 - $20.4 $103,216 - $127,459	-6,248 Reduced 1.89%	323,803 $5.56 Million
Q1 2021 May 07, 2021	BUY	$16.56 - $25.46 $106,298 - $163,427	6,419 Added 1.98%	330,051 $6.6 Million
Q4 2020 Feb 12, 2021	SELL	$15.77 - $19.03 $66,281 - $79,983	-4,203 Reduced 1.28%	323,632 $5.5 Million
Q3 2020 Nov 04, 2020	SELL	$16.59 - $24.79 $77,259 - $115,447	-4,657 Reduced 1.4%	327,835 $5.44 Million
Q2 2020 Aug 12, 2020	SELL	$16.86 - $23.44 $178,867 - $248,674	-10,609 Reduced 3.09%	332,492 $7.7 Million
Q1 2020 May 04, 2020	SELL	$14.47 - $27.96 $167,287 - $323,245	-11,561 Reduced 3.26%	343,101 $6.12 Million
Q4 2019 Feb 05, 2020	BUY	$15.87 - $23.12 $4.43 Million - $6.46 Million	279,291 Added 370.55%	354,662 $7.66 Million
Q3 2019 Nov 08, 2019	BUY	$16.91 - $36.27 $152 - $326	9 Added 0.01%	75,371 $1.37 Million
Q2 2019 Aug 13, 2019	BUY	$31.0 - $36.3 $124,651 - $145,962	4,021 Added 5.64%	75,362 $2.68 Million
Q1 2019 May 06, 2019	SELL	$31.58 - $46.35 $4,073 - $5,979	-129 Reduced 0.18%	71,341 $2.4 Million
Q4 2018 Feb 13, 2019	BUY	$30.43 - $56.65 $331,687 - $617,485	10,900 Added 18.0%	71,470 $2.35 Million
Q3 2018 Nov 09, 2018	BUY	$46.46 - $68.49 $326,753 - $481,690	7,033 Added 13.14%	60,570 $3.69 Million
Q2 2018 Aug 08, 2018	SELL	$46.25 - $104.45 $4.28 Million - $9.66 Million	-92,442 Reduced 63.33%	53,537 $2.61 Million
Q1 2018 May 07, 2018	BUY	$57.4 - $108.44 $1.55 Million - $2.93 Million	27,003 Added 22.7%	145,979 $15.5 Million
Q4 2017 Feb 09, 2018	BUY	$23.02 - $60.5 $14,042 - $36,905	610 Added 0.52%	118,976 $7.11 Million
Q3 2017 Nov 09, 2017	BUY	$17.79 - $24.0 $2.11 Million - $2.84 Million	118,366	118,366 $2.84 Million

Others Institutions Holding NKTR

# of Institutions

145

Shares Held

139M

Call Options Held

32.6K

Put Options Held

14.1K

Deep Track Capital, LP Greenwich, CT

15.9M
Shares

$14.5 Million
0.76% of portfolio
Black Rock Inc. New York, NY

15.2M
Shares

$13.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13.1M
Shares

$11.9 Million
0.0% of portfolio
Eventide Asset Management, LLC Boston, MA

9.4M
Shares

$8.55 Million
0.22% of portfolio
Samlyn Capital, LLC New York, NY

9.2M
Shares

$8.37 Million
0.19% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $171M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account